Citation Impact
Citing Papers
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Clinical lessons learned from the first leg of the CAR T cell journey
2019
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Colorectal cancer
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Programming CAR-T cells to kill cancer
2018
Immunotherapy in colorectal cancer: rationale, challenges and potential
2019
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Making CAR T Cells a Solid Option for Solid Tumors
2018
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML
2017
Bispecific antibodies: a mechanistic review of the pipeline
2019
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
2021
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
Chimeric Antigen Receptor Therapy
2018 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
2019
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Works of Thomas Shum being referenced
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
2017
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice
2018
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
2017
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities
2018